Evidence map›Paper›PMID 40375607›Full record

ArticleJournal of the International AIDS Society2025

Status of HIV vaccine development: progress and promise.

Barton F Haynes, Kevin O Saunders, Beatrice H Hahn, Kevin Wiehe, Lindsey R Baden, George M Shaw

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Barton F HaynesDuke Human Vaccine Institute, Department of Medicine, Duke University, Durham, North Carolina, USA.
Kevin O SaundersDuke Human Vaccine Institute, Department of Surgery, Duke University, Durham, North Carolina, USA.
Beatrice H HahnDepartments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Kevin WieheDuke Human Vaccine Institute, Department of Medicine, Duke University, Durham, North Carolina, USA.
Lindsey R BadenDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
George M ShawDepartments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Funding

Harvard Medical School Vaccine Clinical Trials UnitUM1AI069412 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Lindsey Robert Baden, Daniel R. Kuritzkes · 2012 to 2026
$57.2M
Optimizing glycan shield coverage, germline B cell receptor binding and epitope diversity of V2-apex targeted HIV-1 Env immunogensR37AI150590 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Beatrice H Hahn · 2019 to 2026
$6.9M
Consortia for HIV/AIDS Vaccine DevelopmentHHSNIAID NIH HHS R37 AI150590NIAID NIH HHS UM1 AI069412NIAID UM1 AI144371NIH
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40375607
PMCPMC12081836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.